OECD Home › Science and technology › Publications & Documents › Meetings / Conferences / Agendas
Meetings / Conferences / Agendas
The Working Party on Nanotechnology (WPN) convened at its second meeting 13-16 November 2007 in Paris to finalize work programs for the different projects and move forward especially with the work on statistics and indicators and impacts of nanotechnology on companies and bu
This international symposium examined trends in global networks for innovation in firms as well as implications for policy making.
This conference considered innovation in the software sector from an economic perspective, taking into account the factors that drive innovation, including key framework conditions.
The conference, to be held in Dublin on 2 November 2007, will focus upon the emerging discipline of nanotoxicology and its implications to the broader nanotechnology community. Particular emphasis will be given to the food, environment and medical sectors. The conference will bring together a number of international leaders in the area of nanotoxicology and represents the first conference on this novel topic to be held in Ireland.
The Royal Society organised a workshop that brought together international academic experts and members of the OECD Working Party on Manufactured Nanomaterials (WPNM). This report summarises the main issues discussed during the workshop.
This international conference on "Globalisation and Open Innovation" examined trends in globalisation and "open" models for innovation in firms as well as implications for policy making.
This workshop provided a forum for exchanges of experience and mutual learning on best practices in some OECD countries and the current S&T indicator system in China.
Proceedings of an international workshop to assess the causes behind the low participation of women in scientific careers, especially at senior levels, and to identify good practice policies to attract, recruit and retain women in scientific careers in public and private research.
The main objectives of the workshop were: i) to discuss the history and evolution of the conceptual framework for the evaluation of transgenic plant products in the environment and OECD’s role in the development of that framework; ii) to discuss the current contribution of OECD’s Working Group for the Harmonization of Regulatory Oversight in Biotechnology to risk/ safety assessment practice; and iii) to discuss current risk assessment
Summarises proceedings of a conference looking at examples of human genetic research databases, how they are established, how they are managed and governed, how they might be commercialised, and what the policy considerations might be.